Page 10 - v11i4
P. 10

International Journal of Bioprinting                            Bioprinting for tissue engineering and modeling




            This bioink system holds promise for applications in soft   These synergies are paving the way for next-generation
            tissue engineering and regenerative therapies.     biofabrication  platforms  that  are  smarter,  faster,  and
               Finally,  Gharraei  et  al.   introduced  a  novel  multi-  more versatile.
                                  6
            material bioprinting process using a helical mixer to   Despite these advancements, several challenges
            fabricate fibers with controlled composition. This technique   remain. Ensuring the long-term viability and functionality
            enables the continuous mixing of multiple bioinks during   of  bioprinted  tissues,  achieving  vascularization  and
            extrusion, allowing for spatially heterogeneous constructs   innervation, and scaling up production for clinical use are
            with tunable mechanical and biological properties. The   active  areas  of  research.  Regulatory considerations  also
            approach  opens  new  avenues  for engineering complex   play a crucial role, as the translation of bioprinted products
            tissue interfaces and gradient structures.         from bench to bedside requires rigorous validation and
               The field of bioprinting has witnessed exponential   standardization. Addressing these challenges will require
            growth over the past decade, driven by advances    continued  investment  in  research,  infrastructure,  and
            in  biomaterials,  printing  technologies,  and  cellular   interdisciplinary training.
            engineering. As researchers continue to refine the    Educational initiatives and workforce development are
            resolution, speed, and fidelity of bioprinting systems, the   pivotal to sustaining the rapid advancements in bioprinting.
            ability to replicate native tissue architecture with increasing   As the field evolves, there is an increasing demand for
            complexity  becomes  more  feasible.  This  progress  is  not   professionals who possess interdisciplinary expertise in
            only technological but also conceptual, as interdisciplinary   both  biological  sciences  and  engineering.  Recognizing
            collaborations between engineers, biologists, and clinicians   this need, academic institutions have begun to introduce
            foster innovative approaches to longstanding challenges in   specialized curricula and training programs in bioprinting
            tissue engineering.                                and biofabrication. These initiatives aim to equip emerging
               One of the most promising aspects of bioprinting   scientists and  engineers with  the  theoretical  knowledge
            is its potential to address the shortage of donor organs   and practical skills necessary to innovate in scaffold design,
            and tissues. By enabling the fabrication of patient-  bioink formulation, and bioprinting technologies. 13,14
            specific  constructs,  bioprinting  offers  a  pathway toward   In conclusion, the articles featured in this Special Issue
            personalized  regenerative  therapies.  For  instance,  the   not only highlight the current achievements in bioprinting
            use of patient-derived cells in bioinks can reduce the   for tissue engineering and modeling but also point toward
            risk of immune rejection and improve integration with   a future where engineered tissues and organs become
            host  tissues.   Moreover,  the  ability  to  customize  scaffold   integral components of  medical practice. The  diversity
                      7
            geometry and mechanical properties allows for the creation   of approaches and applications presented here reflects
            of constructs tailored to the anatomical and functional   the richness of the field and its potential to transform
            requirements of individual patients.
                                                               healthcare. We anticipate that continued collaboration,
               In addition to therapeutic applications, bioprinting is   innovation, and investment will accelerate the realization
            revolutionizing the field of in vitro modeling. Traditional   of bioprinting’s full potential.
            two-dimensional cell cultures often fail to recapitulate the
            complex microenvironment of native tissues, limiting their   Conflict of interest
            utility in drug discovery and disease research. Bioprinted   Both Dr. Liqun Ning and Dr. Xiongbiao Chen are Guest
            models, by contrast, can incorporate multiple cell types,
            extracellular matrix components, and spatial organization,   Editors for this Special Issue. Dr. Xiongbiao Chen is
            providing more physiologically relevant platforms. These   also a  co-author for two of the six papers published
            models are particularly valuable for studying diseases such   in  this  Special  Issue.  The  authors  declare  they  have  no
            as cancer, fibrosis, and infectious diseases, where cell–cell   competing interests.
            and cell–matrix interactions play critical roles. 8,9  References
               The  integration of  bioprinting  with  other  emerging
            technologies further expands its capabilities. For example,   1.   Khoshnood N, Frampton JP, Badri A, Zamanian A.
            combining bioprinting with microfluidics enables the   3D bioprinting of betamethasone-loaded gellan gum–
            creation of organ-on-a-chip systems that mimic the    polyethyleneimine composite hydrogels for ocular drug
            dynamic flow conditions of the human body.  Similarly,   delivery. Int J Bioprint. 2024;10(4):3440.
                                                 10
            the use of artificial intelligence and machine learning   doi:10.36922/ijb.3440
            can optimize printing parameters and predict construct   2.   Kühl  J,  Krümpelmann  SM,  Hildebrandt  L,  Bruhn  M,
            behavior, enhancing reproducibility and efficiency. 11,12    Fuchs S. Nanomaterial-modified bioinks for DLP-based

            Volume 11 Issue 4 (2025)                        2                             doi: 10.36922/IJB025300302
   5   6   7   8   9   10   11   12   13   14   15